These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733 [TBL] [Abstract][Full Text] [Related]
8. Predictors of Higher Frequency of Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy. Grbović A; Pavlović S; Žugić V Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138281 [No Abstract] [Full Text] [Related]
9. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Kutyifa V; Kloppe A; Zareba W; Solomon SD; McNitt S; Polonsky S; Barsheshet A; Merkely B; Lemke B; Nagy VK; Moss AJ; Goldenberg I J Am Coll Cardiol; 2013 Mar; 61(9):936-44. PubMed ID: 23449428 [TBL] [Abstract][Full Text] [Related]
10. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related]
11. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial. Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239 [TBL] [Abstract][Full Text] [Related]
12. Effect of digoxin on shocks in cardiac resynchronization therapy-defibrillator patients with coronary artery disease. Adelstein E; Schwartzman D; Jain S; Bazaz R; Saba S Am J Cardiol; 2014 Mar; 113(6):970-5. PubMed ID: 24440327 [TBL] [Abstract][Full Text] [Related]
13. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954 [TBL] [Abstract][Full Text] [Related]
14. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study. Gasparini M; Leclercq C; Yu CM; Auricchio A; Steinberg JS; Lamp B; Klersy C; Leyva F Am Heart J; 2014 Feb; 167(2):203-209.e1. PubMed ID: 24439981 [TBL] [Abstract][Full Text] [Related]
15. [Cardiac resynchronization therapy: mortality, rehospitalization, and procedure-related complications. A three-year single-center observational study within the Italian Health System]. Palmieri V; Pezzullo S; Coltorti F; Tavoletta V; Langella A; Scarnera P; Russo C; Celentano A G Ital Cardiol (Rome); 2012 May; 13(5):369-76. PubMed ID: 22539143 [TBL] [Abstract][Full Text] [Related]
16. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation. Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089 [TBL] [Abstract][Full Text] [Related]
17. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C; Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006 [TBL] [Abstract][Full Text] [Related]
18. Reduced risk of life-threatening ventricular tachyarrhythmias with cardiac resynchronization therapy: relationship to left ventricular ejection fraction. Kutyifa V; Moss AJ; Solomon SD; McNitt S; Aktas MK; Barsheshet A; Merkely B; Zareba W; Goldenberg I Eur J Heart Fail; 2015 Sep; 17(9):971-8. PubMed ID: 26173635 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ; Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819 [TBL] [Abstract][Full Text] [Related]
20. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Manfredi JA; Al-Khatib SM; Shaw LK; Thomas L; Fogel RI; Padanilam B; Rardon D; Vatthyam R; Gemma LW; Golden K; Prystowsky EN Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):257-64. PubMed ID: 23443618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]